Related Experiment Video
Updated: Jan 29, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
The effect and optimal parameters of electroacupuncture on post-stroke dysphagia: a meta-analysis of randomized
Mengqi Yue1,2, Xu Chen1,2, Xiaolin Yang1,2
1Second Clinical Medical College, Yunnan University of Chinese Medicine, Kunming, China.
Objective:
This research aimed to assess the effectiveness of electroacupuncture in treating post-stroke dysphagia (PSD) and to investigate the optimal stimulation parameters.
Methods:
We conducted a comprehensive review of eight databases: PubMed, Web of Science, Cochrane Library, Embase, CBM, CNKI, Wan Fang, and VIP. Randomized controlled trials (RCTs) on electroacupuncture for the treatment of PSD published between the inception of these databases and March 19, 2025, were integrated. The treatment's effectiveness was evaluated using several outcome indicators, including the Video Fluoroscopic Swallow Study (VFSS) and the Water Swallowing Test (WST), which collectively assess swallowing function. Two independent reviewers performed risk of bias (ROB 2) evaluations, frequency of use for electroacupuncture parameter combinations through the R language (version 4.5.1), and data analysis using Review Manager (RevMan) version 5.4 and Stata SE 18.
Results:
This analysis encompassed a total of 30 RCTs that involved 2,290 patients. The research demonstrated an overall efficiency of (RR = 1.29, 95% CI: 1.23-1.34, p < 0.0001; I2 = 13%, fixed-effects model). The mean differences for the various scales were as follows: VFSS (MD = 1.67, 95% CI: 1.26-2.09, p < 0.01; I2 = 57%, random effects model). WST (MD = -0.75, 95% CI: -0.93 to -0.57, p < 0.01; I2 = 54%, random effects model). Aspiration pneumonia (RR = 0.41, 95% CI: 0.25 to 0.68, p = 0.0005; I2 = 8%, fixed effect model). Subgroup analysis revealed significant disparities between the various waveforms (Dense-sparse wave (Ds-W): RR = 1.58, p = 0.003 < 0.01) and the distinctions among the top three combinations of electroacupuncture parameter usage frequency (≥ 30 min + Ds-W, ≥ 30 min + Continuous Wave (C-W), and ≥ 30 min + Intermittent Wave (I-W) groups) were statistically significant (≥ 30 min + Ds-W: RR = 1.55, p = 0.03 < 0.05). In addition, there were no statistically significant differences between the other electroacupuncture parameter subgroups, which included the stimulation frequency and single treatment time (p > 0.05).
Conclusion:
Electroacupuncture, in conjunction with dysphagia training, is more effective than a solitary treatment in patients with PSD. Furthermore, applying waveforms with Ds-W might enhance the effectiveness of electroacupuncture for PSD. However, the higher risk of bias (ROB) in the included trials indicates that the quality of evidence for the outcomes of these assessments may be jeopardized. Thus, further high-quality clinical trials are urgently required to evaluate the efficacy and effectiveness of electroacupuncture parameters (waveforms) in the treatment of PSD, ultimately increasing the total level of evidence (PROSPERO registration number: CRD420251014881, https://www.crd.york.ac.uk/prospero/).
More Related Videos
08:53Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
03:26Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
Published on: March 8, 2024
Related Concept Videos
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
Statistical Software for Data Analysis and Clinical Trials
Clinical Trials: Overview
Trial and Error and Algorithm
Clinical Trials
There are four phases in a clinical trial. A phase one...
Random Error